Cegedim S.A (CGM) | Stock Overview & Key Data
Cegedim S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €44.50 on January 29, 2018
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2016
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cegedim S.A
CGM
|
188.10M Mid-cap | 0.00% | -0.87% | 0.44% | 0.44% | 0.44% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% |
|
Equasens
EQS
|
589.23M Mid-cap | 0.26% | 3.49% | 11.08% | -7.54% | -13.94% | -20.51% | -51.36% | -56.42% | 60.55% | 266.39% | 266.39% |
|
Smaio S.A
ALSMA
|
47.02M Small-cap | 2.30% | 15.03% | 26.86% | 31.56% | 44.39% | 128.87% | 219.42% | 65.36% | 65.36% | 65.36% | 65.36% |
|
Abl Diagnostics
ABLD
|
44.38M Small-cap | -2.29% | 44.92% | -0.58% | 11.76% | -10.94% | -37.25% | -41.03% | 51.33% | 95.43% | 36.80% | 36.80% |
|
Intrasense S.A
ALINS
|
11.80M Small-cap | 0.00% | 4.55% | -4.17% | -11.54% | 0.00% | -25.00% | -45.45% | -68.42% | -73.91% | -95.75% | -95.75% |
|
Media Lab S.p.A
MLLAB
|
8.06M Small-cap | 0.00% | -0.59% | 1.20% | 9.74% | -5.59% | 53.64% | 152.24% | 95.38% | -1.46% | -1.46% | -1.46% |
Ownership & Short Interest
Calculate Your Cegedim S.A Investment Returns
Long-Term Investment Performance Analysis
Cegedim S.A stock price in Mar 2026 was €10.85, A €1,000.00 lump sum investment in Cegedim S.A made 0 years ago would be worth approximately €1,058.06 today, representing a positive return of 5.81%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CGM's 52-week high and low?
- In the last 52 weeks, Cegedim S.A reached a high of €15.30 (on January 5, 2026) and a low of €8.50 (on March 23, 2026).
- What is the market cap and P/E ratio for CGM?
- Curious about Cegedim S.A's size and valuation? Its market capitalization stands at 188.10M. When it comes to valuation, the P/E ratio (trailing twelve months) is 92.86, and the forward P/E (looking ahead) is 6.84.
- Does CGM pay dividends? If so, what's the yield?
- As for dividends, Cegedim S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Cegedim S.A's main competitors or similar companies to consider before investing?
When looking at Cegedim S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS589.23M Healthcare Health Information Services -20.51% -51.36% Smaio S.A
ALSMA47.02M Healthcare Health Information Services 128.87% 219.42% Abl Diagnostics
ABLD44.38M Healthcare Health Information Services -37.25% -41.03% Intrasense S.A
ALINS11.80M Healthcare Health Information Services -25.00% -45.45% Media Lab S.p.A
MLLAB8.06M Healthcare Health Information Services 53.64% 152.24% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cegedim S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Cegedim S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -4.95%, the Debt to Equity ratio from the most recent quarter is 115.34, and its Gross Profit Margin stands at 62.17%.
- What is the recent revenue and earnings growth for CGM?
- Looking at Cegedim S.A's growth, its revenue over the trailing twelve months (TTM) was €654M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.50%, and quarterly earnings saw a YoY growth of 105.57%.
- How much of CGM stock is held by insiders and institutions?
- Wondering who owns Cegedim S.A stock? Company insiders (like executives and directors) hold about 57.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 16.46%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.